Category Archive for : ‘Projects’

The function of the NK killer receptor NKp46 in immunosurveillance of cytomegalovirus and influenza viruses

Full title: The function of the NK killer receptor NKp46 in immunosurveillance of cytomegalovirus and influenza viruses

Grantors: The Ministry of Science, Education and Sports of the Republic of Croatia & the Israel Ministry of Science, Culture and Sport

Grantors’ websites: http://public.mzos.hr/Default.aspx?sec=2428

http://www.most.gov.il/English/

Programme: Croatia-Israel Joint Research Programme

Programme websites: http://ra.haifa.ac.il/showpage.asp?Idnn=959&namef=MOST&otkuda=search.asp&order=&view

Duration: 2009-2010

Total funding (Croatian project partner – Center for Proteomics): USD 50.000

Principal Investigators: Stipan Jonjic, Faculty of Medicine University of Rijeka and Ofer Mandelboim, Hadassah Medical School, the Hebrew University Jerusalem,

A Transcriptomic Approach to Viral Disease Research

Full title: A Transcriptomic Approach to Viral Disease Research

Grantor: Unity through Knowledge Fund (UKF)

Grantor’s website: www.ukf.hr

Programme: Research Cooperability

Programme website: http://www.ukf.hr/default.aspx?id=18

Duration: 2007-2010 (36 months)

Coordinator: Joanne Trgovcich, Ohio State University, Columbus OH, USA

Partner from the Center for Proteomics: Stipan Jonjic

Total project financing (Center for Proteomics + Ohio State University): EUR 190.000

No. of participants: 2

Brief description:

Human cytomegalovirus (HCMV) is a member of beta-herpesvirus family and is widely distributed throughout world populations. After infection, which usually passes with no symptoms, it establishes a life-long persistence with minimal or

NK Defense and Therapy

Full title: Natural Killer Cell-Mediated Anti-Viral and Anti Tumor Defense and Therapy: Integrated research training in molecular medicine, bioinformatics and issues of biotech patents and SME business

Grantor: European Commission: 6th Framework Programme (FP6)

Grantor’s website: http://cordis.europa.eu/fp6/

Programme: Marie Curie Research Training Networks

Programme website: http://cordis.europa.eu/mariecurie-actions/rtn/home.html

Duration: 2006-2009

Coordinator: Erhard Hofer, Medical University of Vienna, Austria

 No. of participants: 11

Partner from the Center for Proteomics: Stipan Jonjic

Project website: http://www.nkdefense.eu/

Brief description:

The general objective of this project was to establish a research training network of postgraduate students and early post-doctoral fellows, to perform basic research

CAPRI

Full title: Establishment of high-throughput monoclonal antibody production and hybridoma bank

Grantor: European Commission: 6th Framework Programme (FP6)

Grantor’s website: http://cordis.europa.eu/fp6/

Programme: International cooperation activities (INCO)

Programme website: http://cordis.europa.eu/inco/home_en.html

Duration: 2006-2008

Coordinator: Stipan Jonjic, Faculty of Medicine University of Rijeka

No. of participants: 3

Partners: Jürgen Haas, Max von-Pettenkofer Institute, Munich

Filip Culo, Medical Faculty University of Mostar

Total funding: EUR 248.152

Project website: http://www.capri.com.hr/establishment-of-high-throughput-monoclonal-antibody-production-and-hybridoma-bank.html

Brief description:

The basic technology for protein expression and high-throughput mAb production at the Center for Proteomics was organized and supported through this grant, with Max von-Pettenkofer-Institut, LMU, Munich and Medical Faculty University of Mostar, as partners.

The

JEZGRA – 17

Full title: The Center for Monoclonal Antibody Production

Grantor: Ministry of Science, Education and Sports of the Republic of Croatia

Grantor’s website: http://public.mzos.hr/Default.aspx?sec=2428

Programme: JEZGRA

Duration: 2005 – 2007

Coordinator: Stipan Jonjic, Faculty of Medicine University of Rijeka

No. of participants: 1

Total funding: EUR 499.104

Brief description:

The main objective of the project JEZGRA-17 was setting up of the Center for Proteomics. The Center’s basic activity involves high-throughput monoclonal antibody production. This includes the implementation of technologies and professional personnel training for the following procedures: gene expression and setup of specific proteins for immunization, breeding and